Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Hollemans

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 12, 2019
Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the StromaMaria Caroline Vos, Eva Hollemans, Sophieke C H A van der Steen, et al.
Virchows Archiv : an International Journal of Pathology|August 21, 2020
Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcomeMargaretha A van der Slot, Eva Hollemans, Michael A den Bakker, et al.
Histopathology|June 17, 2020
Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimensL Lucia Rijstenberg, Tim Hansum, Eva Hollemans, et al.
Virchows Archiv : an International Journal of Pathology|February 14, 2022
Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomyNeslisah Seyrek, Eva Hollemans, Eleni-Rosalina Andrinopoulou, et al.
Clinical Genitourinary Cancer|August 9, 2023
Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN ToolsMichelle R Downes, Kristen N Liu, Yanhong Yu, et al.
Histopathology|October 27, 2021
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patientsNeslisah Seyrek, Eva Hollemans, Susanne Osanto, et al.
Journal of Ovarian Research|September 4, 2016
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancerMaria Caroline Vos, Eva Hollemans, Nicole Ezendam, et al.
European Urology|August 24, 2019
Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade GroupsGeert J L H van Leenders, Charlotte F Kweldam, Eva Hollemans, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2020
Clinicopathological characteristics of glomeruloid architecture in prostate cancerEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2020
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patientsEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 12, 2019
Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the StromaMaria Caroline Vos, Eva Hollemans, Sophieke C H A van der Steen, et al.
Virchows Archiv : an International Journal of Pathology|August 21, 2020
Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcomeMargaretha A van der Slot, Eva Hollemans, Michael A den Bakker, et al.
Histopathology|June 17, 2020
Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimensL Lucia Rijstenberg, Tim Hansum, Eva Hollemans, et al.
Virchows Archiv : an International Journal of Pathology|February 14, 2022
Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomyNeslisah Seyrek, Eva Hollemans, Eleni-Rosalina Andrinopoulou, et al.
Clinical Genitourinary Cancer|August 9, 2023
Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN ToolsMichelle R Downes, Kristen N Liu, Yanhong Yu, et al.
Histopathology|October 27, 2021
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patientsNeslisah Seyrek, Eva Hollemans, Susanne Osanto, et al.
Journal of Ovarian Research|September 4, 2016
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancerMaria Caroline Vos, Eva Hollemans, Nicole Ezendam, et al.
European Urology|August 24, 2019
Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade GroupsGeert J L H van Leenders, Charlotte F Kweldam, Eva Hollemans, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2020
Clinicopathological characteristics of glomeruloid architecture in prostate cancerEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2020
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patientsEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Pageof 3